ICD-10-CM Billable Code

Z79.85

Long-term (current) use of injectable non-insulin antidiabetic drugs

Clinical Classification Guidelines

Excludes Type 2

  • long term (current) use of insulin (Z79.4)
  • long term (current) use of oral hypoglycemic drugs (Z79.84)

Medical Intelligence & Overview

ICD-10 Code Z79.85 pertains to the ongoing use of injectable medications designed to help control blood sugar levels in people with diabetes. These medications are often prescribed when oral medications are insufficient or inappropriate. Long-term management of diabetes involves a comprehensive approach, and injectable non-insulin antidiabetic drugs play a vital role for many individuals. This guide offers a clear understanding of this condition, its causes, symptoms, diagnosis, and treatment options.

Causes & Symptoms

Clinical Causes: Type 2 diabetes mellitus that has not been adequately controlled with oral medications. Presence of complications or specific health considerations requiring injectable therapy. Preference for injectable medications due to their efficacy or patient response. Transition from insulin therapy to alternative injectable medications based on patient needs. Chronic management of diabetes as part of an individualized treatment plan.

Key Symptoms: Persistent high blood sugar levels (hyperglycemia). Increased thirst and frequent urination. Fatigue or feeling tired throughout the day. Blurred vision. Slow healing of cuts or frequent infections. Unintended weight loss or gain. Numbness or tingling sensations in the hands or feet.

Diagnostic & Treatment

Diagnosis Path: The diagnosis of the long-term use of injectable non-insulin antidiabetic drugs is primarily based on medical history and medication records. Healthcare professionals evaluate the patient's treatment plan and confirm the ongoing use of these medications. Blood tests, such as HbA1c, may be used to assess blood sugar control over time. Monitoring the effectiveness of therapy and assessing for potential complications are essential components of ongoing care.

Treatment Protocols: Managing long-term injectable non-insulin antidiabetic therapy involves several key aspects:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z79.85 a billable ICD-10 code?
Yes, Z79.85 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z79.85?
Clinical documentation must specify the nature of Long-term (current) use of injectable non-insulin antidiabetic drugs and any associated comorbidities for accurate reporting.

Cite this Clinical Reference